Marina Nelen
Vice President & Head of Drug Discovery Foghorn Therapeutics
Seminars
Thursday 29th October 2026
Proximity by Design: Harnessing Induced Proximity for Challenging Targets
10:30 am
- Introducing a multi-pronged strategy across small molecule modalities, designed to address target-specific challenges through multiple orthogonal approaches
- Leveraging Foghorn's expertise in profiling ternary interactions and mechanism-related characteristics to streamline lead development
- Expanding the discovery portfolio to explore a range of induced proximity approaches for reprogramming transcription
